CARE guidelines for case reports: explanation and elaboration document. Translation into Russian

Abstract

BACKGROUND: Well-written and transparent case reports (1) reveal early signals of potential benefits, harms, and information on the use of resources; (2) provide information for clinical research and clinical practice guidelines, and (3) inform medical education. High-quality case reports are more likely when authors follow reporting guidelines. During 2011–2012, a group of clinicians, researchers, and journal editors developed recommendations for the accurate reporting of information in case reports that resulted in the CARE (CAse REport) Statement and Checklist. They were presented at the 2013 International Congress on Peer Review and Biomedical Publication, have been endorsed by multiple medical journals, and translated into nine languages.

OBJECTIVES: This explanation and elaboration document has the objective to increase the use and dissemination of the CARE Checklist in writing and publishing case reports.

ARTICLE DESIGN AND SETTING: Each item from the CARE Checklist is explained and accompanied by published examples. The explanations and examples in this document are designed to support the writing of high-quality case reports by authors and their critical appraisal by editors, peer reviewers, and readers.

RESULTS AND CONCLUSION: This article and the 2013 CARE Statement and Checklist, available from the CARE website [www.care-statement.org] and the EQUATOR Network [www.equator-network.org], are resources for improving the completeness and transparency of case reports.

SOURCE: This article is a translation of the original paper “CARE guidelines for case reports: explanation and elaboration document” in the Journal of Clinical Epidemiology (doi: 10.1016/j.jclinepi.2017.04.026), prepared under the permission of the copyright holder (Elsevier Inc.), with supervision from the Scientific Editor by Professor E.G. Starostina, MD, PhD (translator) (Moscow, Russia).

Keywords

case report / case study / EQUATOR network / health research reporting guidelines / CARE guideline / timelines / N-of-1

References

[1] Vandenbroucke JP. In defense of case reports and case series. Ann Intern Med. 2001;134(4):330–334. doi: 10.7326/0003-4819-134-4-200102200-00017

[2] Vandenbroucke J.P. In defense of case reports and case series // Ann Intern Med. 2001. Vol. 134, N 4. Р. 330–334. doi: 10.7326/0003-4819-134-4-200102200-00017

[3] Aronson JK. Anecdotes as evidence. BMJ. 2003;326(2):1346. doi: 10.1111/j.1365-2753.2005.00527.x

[4] Aronson J.K. Anecdotes as evidence // BMJ 2003. Vol. 326, N 2. Р. 1346. doi: 10.1111/j.1365-2753.2005.00527.x

[5] Sun GH, Aliu O, Hayward RA. Open-access electronic case report journals: the rationale for case report guidelines. J Clin Epidemiol. 2013;66(10):1065–1070. doi: 10.1016/j.jclinepi.2013.04.001

[6] Sun G.H., Aliu O., Hayward R.A. Open-access electronic case report journals: the rationale for case report guidelines // J Clin Epidemiol. 2013. Vol. 66, N 10. Р. 1065–1070. doi: 10.1016/j.jclinepi.2013.04.001

[7] Akers KG. New journal for publishing medical case reports. J Med Libr Assoc. 2016;104(2):146–149. doi: 10.3163/1536-5050.104.2.010

[8] Akers K.G. New journal for publishing medical case reports // J Med Libr Assoc. 2016. Vol. 104, N 2. Р. 146–149. doi: 10.3163/1536-5050.104.2.010

[9] McBride WG. Thalidomide and congenital abnormalities. Lancet. 1961;278(7216):1358. doi: 10.1016/S0140-6736(61)90927-8

[10] McBride W.G. Thalidomide and congenital abnormalities // Lancet 1961. Vol. 278, N 7216. Р. 1358. doi: 10.1016/S0140-6736(61)90927-8

[11] CDC. Pneumocystis pneumonia e Los Angeles. Morbidity Mortality Weekly Rep. 1981;30(21):250–252.

[12] CDC. Pneumocystis pneumonia e Los Angeles // Morbidity Mortality Weekly Rep. 1981. Vol. 30, N 21. Р. 250–252.

[13] Rison R, Helfgott M. Acute paradoxical embolic cerebral ischemia secondary to possible May-Thurner syndrome and an atrial septal defect: a case report. J Med Case Rep. 2013;7:172. doi: 10.1186/1752-1947-7-172

[14] Rison R., Helfgott M. Acute paradoxical embolic cerebral ischemia secondary to possible May-Thurner syndrome and an atrial septal defect: a case report // J Med Case Rep. 2013. Vol. 7. Р. 172. doi: 10.1186/1752-1947-7-172

[15] Driggers RW, Ho CY, Korhonen EM, et al. Zika virus infection with prolonged maternal viremia and fetal brain abnormalities. N Engl J Med. 2016;374(22):2142–2151. doi: 10.1056/NEJMoa1601824

[16] Driggers R.W., Ho C.Y., Korhonen E.M., et al. Zika virus infection with prolonged maternal viremia and fetal brain abnormalities // N Engl J Med. 2016. Vol. 374, N 22. Р. 2142–2151. doi: 10.1056/NEJMoa1601824

[17] Kaszkin-Bettag M, Hildebrandt W. Case report on cancer therapies: the urgent need to improve the reporting quality. Glob Adv Health Med. 2012;1(2):8–10. doi: 10.7453/gahmj.2012.1.2.002

[18] Kaszkin-Bettag M., Hildebrandt W. Case report on cancer therapies: the urgent need to improve the reporting quality // Glob Adv Health Med. 2012. Vol. 1, N 2. Р. 8–10. doi: 10.7453/gahmj.2012.1.2.002

[19] Richason TP, Paulson SM, Lowenstein SR, Heard KJ. Case reports describing treatments in the emergency medicine literature: missing and misleading information. BMC Emerg Med. 2009;9:10. doi: 10.1186/1471-227X-9-10

[20] Richason T.P., Paulson S.M., Lowenstein S.R., Heard K.J. Case reports describing treatments in the emergency medicine literature: missing and misleading information // BMC Emerg Med. 2009. Vol. 9. Р. 10. doi: 10.1186/1471-227X-9-10

[21] Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. Plos Med. 2010;7(2): e1000217. doi: 10.1371/journal.pmed.1000217

[22] Moher D., Schulz K.F., Simera I., Altman D.G. Guidance for developers of health research reporting guidelines // Plos Med. 2010. Vol. 7, N 2. Р. e1000217. doi: 10.1371/journal.pmed.1000217

[23] Gagnier JJ, Kienle G, Altman DG, et al.; The CARE Group. The CARE guidelines: consensus-based clinical case report guideline development. Glob Adv Health Med. 2013;2(5):38–43. doi: 10.7453/gahmj.2013.008

[24] Gagnier J.J., Kienle G., Altman D.G., et al.; The CARE Group. The CARE guidelines: consensus-based clinical case report guideline development // Glob Adv Health Med. 2013. Vol. 2, N 5. Р. 38–43. doi: 10.7453/gahmj.2013.008

[25] Galipeau J, Barbour V, Baskin P, et al. A scoping review of competencies for scientific editors of biomedical journals. BMC Med. 2016;14:16. doi: 10.1186/s12916-016-0561-2

[26] Galipeau J., Barbour V., Baskin P., et al. A scoping review of competencies for scientific editors of biomedical journals // BMC Med. 2016. Vol. 14. Р. 16. doi: 10.1186/s12916-016-0561-2

[27] Kienle GS, Meusers M, Quecke B, Hilgard D. Patient-centered Diabetes care in children: an integrated, Individualized, Systemsoriented, and multi-Disciplinary Approach. Glob Adv Health Med. 2013;2(2):12–19. doi: 10.7453/gahmj.2013.005

[28] Kienle G.S., Meusers M., Quecke B., Hilgard D. Patient-centered Diabetes care in children: an integrated, Individualized, Systemsoriented, and multi-Disciplinary Approach // Glob Adv Health Med. 2013. Vol. 2, N 2. Р. 12–19. doi: 10.7453/gahmj.2013.005

[29] Jenicek M. Clinical case reporting in evidence-based medicine. 2nd ed. London/New York: Arnold and Oxford University Press; 2001. 231 р.

[30] Jenicek M. Clinical case reporting in evidence-based medicine. 2nd ed. London/New York: Arnold and Oxford University Press,2001.231 р.

[31] Wei J, Chang CY, Chuang YC, et al. Successful heart transplantation after 13 hours of donor heart ischemia with the Use of HTK Solution: a case report. Transplant Proc. 2005;37(5):2253–2254. doi: 10.1016/j.transproceed.2005.03.055

[32] Wei J., Chang C.Y., Chuang Y.C., et al. Successful heart transplantation after 13 hours of donor heart ischemia with the Use of HTK Solution: a case report // Transplant Proc 2005. Vol. 37, N 5. Р. 2253–2254. doi: 10.1016/j.transproceed.2005.03.055

[33] Gish DS, Baer JA, Crabtree GS, et al. Impending aortic aneurysm rupture ― a case report and review of the warning signs. J Community Hosp Intern Med Perspect. 2016;6(5):32217. doi: 10.3402/jchimp.v6.32217

[34] Gish D.S., Baer J.A., Crabtree G.S., et al. Impending aortic aneurysm rupture ― a case report and review of the warning signs // J Community Hosp Intern Med Perspect. 2016. Vol. 6, N 5. Р. 32217. doi: 10.3402/jchimp.v6.32217

[35] Cooper D. How to write an original research paper (and get it published). J Med Lib Assoc. 2015;103(2):67–68. doi: 10.3163/1536-5050.103.2.001

[36] Cooper D. How to write an original research paper (and get it published) // J Med Lib Assoc. 2015. Vol. 103, N 2. Р. 67–68. doi: 10.3163/1536-5050.103.2.001

[37] Jha KN. How to write articles that get published. J Clin Diagn Res. 2014;8(9):XG01–XG03. doi: 10.7860/JCDR/2014/8107.4855

[38] Jha K.N. How to write articles that get published // J Clin Diagn Res. 2014. Vol. 8, N 9. Р. XG01–XG03. doi: 10.7860/JCDR/2014/8107.4855

[39] Cohen H. How to write a patient case report. Am J HealthSyst Pharm. 2006;63(19):1888–1892. doi: 10.2146/ajhp060182

[40] Cohen H. How to write a patient case report // Am J HealthSyst Pharm. 2006. Vol. 63, N 19. Р. 1888–1892. doi: 10.2146/ajhp060182

[41] Hopewell S, Clarke M, Moher D, et al. CONSORT for reporting randomized controlled trials in journal and Conference abstracts: explanation and elaboration. Plos Med. 2008;5(1):e20. doi: 10.1371/journal.pmed.0050020

[42] Hopewell S., Clarke M., Moher D., et al. CONSORT for reporting randomized controlled trials in journal and Conference abstracts: explanation and elaboration // Plos Med. 2008. Vol. 5, N 1. Р. e20. doi: 10.1371/journal.pmed.0050020

[43] Davidson A, Delbridge E. How to write a research paper. Paediatrics Child Health. 2012;22(2):61–65. doi: 10.1016/j.paed.2011.05.009

[44] Davidson A., Delbridge E. How to write a research paper // Paediatrics Child Health. 2012. Vol. 22, N 2. Р. 61–65. doi: 10.1016/j.paed.2011.05.009

[45] Vandenbroucke J. Case reports in an evidence-based world. JR Soc Med. 1999;92(4):159–162. doi: 10.1177/014107689909200401

[46] Vandenbroucke J. Case reports in an evidence-based world // JR Soc Med. 1999. Vol. 92, N 4. Р. 159–162. doi: 10.1177/014107689909200401

[47] Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a t-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (aids). Science. 1983;220(4599):868–871. doi: 10.1126/science.6189183

[48] Barre-Sinoussi F., Chermann J.C., Rey F., et al. Isolation of a t-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (aids) // Science. 1983. Vol. 220, N 4599. Р. 868–871. doi: 10.1126/science.6189183

[49] Labris G, Katsanos A, Karapetsa M, et al. Association between isotretinoin use and central retinal vein occlusion in an adolescent with minor predisposition for thrombotic incidents: a case report. J Med Case Rep. 2009;3:58. doi: 10.1186/1752-1947-3-58

[50] Labris G., Katsanos A., Karapetsa M., et al. Association between isotretinoin use and central retinal vein occlusion in an adolescent with minor predisposition for thrombotic incidents: a case report // J Med Case Rep. 2009. Vol. 3. Р. 58. doi: 10.1186/1752-1947-3-58

[51] Green BN, Johnson CD. How to write a case report for publication. J Chiropr Med. 2006;5(2):72e82. doi: 10.1016/S0899-3467(07)60137-2

[52] Green B.N., Johnson C.D. How to write a case report for publication // J Chiropr Med. 2006. Vol. 5, N 2. Р. 72–82. doi: 10.1016/S0899-3467(07)60137-2

[53] Rison R.A. A guide to writing case reports for the journal of medical case reports and BioMed central research notes. J Med Case Rep. 2013;7:239. doi: 10.1186/1752-1947-7-239

[54] Rison R.A. A guide to writing case reports for the journal of medical case reports and BioMed central research notes // J Med Case Rep. 2013. Vol. 7. Р. 239. doi: 10.1186/1752-1947-7-239

[55] Turner L, Shamseer L, Altman DG, et al. Does use of the CONSORT Statement impact the completeness of reporting of randomized controlled trials published in medical journals? A Cochrane review. Syst Rev. 2012;1:60. doi: 10.1186/2046-4053-1-60

[56] Turner L., Shamseer L., Altman D.G., et al. Does use of the CONSORT Statement impact the completeness of reporting of randomized controlled trials published in medical journals? A Cochrane review // Syst Rev. 2012. Vol. 1. Р. 60. doi: 10.1186/2046-4053-1-60

[57] Chang HC, Burbridge H, Wong C. Extensive deep vein thrombosis following prolonged gaming (‘gamer’s thrombosis’): a case report. J Med Case Rep. 2013;7:235. doi: 10.1186/1752-1947-7-235

[58] Chang H.C., Burbridge H., Wong C. Extensive deep vein thrombosis following prolonged gaming (‘gamer’s thrombosis’): a case report // J Med Case Rep. 2013. Vol. 7. Р. 235. doi: 10.1186/1752-1947-7-235

[59] Gottlieb M, Schroff R, Schanker HM, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously health homosexual men; evidence of a new acquired cellular immunodeficiency. N Engl J Med. 1981;305:1425–1431. doi: 10.1056/NEJM198112103052401

[60] Gottlieb M., Schroff R., Schanker H.M., et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously health homosexual men; evidence of a new acquired cellular immunodeficiency // N Engl J Med. 1981. Vol. 305, N 24. Р. 1425–1431. doi: 10.1056/NEJM198112103052401

[61] Lang TA, Talerico C, Siontis GC. Documenting clinical and laboratory images in publications: the CLIP principles. Chest. 2012;141(16):1626–1632. doi: 10.1378/chest.11-1800

[62] Lang T.A., Talerico C., Siontis G.C. Documenting clinical and laboratory images in publications: the CLIP principles // Chest. 2012. Vol. 141, N 16. Р. 1626–1632. doi: 10.1378/chest.11-1800

[63] Dahlbäck B, Carlsson M, Svensson P. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci. 1993;90(3):1004. doi: 10.1073/pnas.90.3.1004

[64] Dahlbäck B., Carlsson M., Svensson P. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C // Proc Natl Acad Sci. 1993. Vol. 90, N 3. Р. 1004. doi: 10.1073/pnas.90.3.1004

[65] Namas R, Marquardt A. Case report and literature review: Quinacrine-induced Cholestatic Hepatitis in undifferentiated connective tissue disease. J Rheumatol. 2015;42(7):1354–1355. doi: 10.3899/jrheum.150050

[66] Namas R., Marquardt A. Case report and literature review: Quinacrine-induced Cholestatic Hepatitis in undifferentiated connective tissue disease // J Rheumatol. 2015. Vol. 42, N 7. Р. 1354–1355. doi: 10.3899/jrheum.150050

[67] Rajakumar D, Rosenberg AM. Mycobacterium tuberculosis monoarthritis in a child. Pediatr Rheumatol Online J. 2008;6:15. doi: 10.1186/1546-0096-6-15

[68] Rajakumar D., Rosenberg A.M. Mycobacterium tuberculosis monoarthritis in a child // Pediatr Rheumatol Online J. 2008. Vol. 6. Р. 15. doi: 10.1186/1546-0096-6-15

[69] Sevinc M, Basturk T, Sahutoglu T, et al. Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report. J Med Case Rep. 2015;9:92. doi: 10.1186/s13256-015-0575-y

[70] Sevinc M., Basturk T., Sahutoglu T., et al. Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report // J Med Case Rep. 2015. Vol. 9. Р. 92. doi: 10.1186/s13256-015-0575-y

[71] Cella D, Stone AA. Health-related quality of life measurement in oncology: Advances and opportunities. Am Psychol. 2015;70(2):175–185. doi: 10.1037/a0037821

[72] Cella D., Stone A.A. Health-related quality of life measurement in oncology: Advances and opportunities // Am Psychol. 2015. Vol. 70, N 2. Р. 175–185. doi: 10.1037/a0037821

[73] Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58(5):295–300.

[74] Hill A.B. The Environment and Disease: Association or Causation? // Proc R Soc Med. 1965. Vol. 58, N 5. Р. 295–300.

[75] Rison RA. Branch facial nerve trauma after superficial temporal artery biopsy: a case report. J Med Case Rep. 2011;5:34. doi: 10.1186/1752-1947-5-34

[76] Rison R.A. Branch facial nerve trauma after superficial temporal artery biopsy: a case report // J Med Case Rep. 2011. Vol. 5. Р. 34. doi: 10.1186/1752-1947-5-34

[77] Mora JR, Rison RA, Beudoun SR. Chiari malformation type I with cervicothoracic syringomyelia masquerading as bibrachial amyotrophy: a case report. J Med Case Rep. 2015;9:11. doi: 10.1186/1752-1947-9-11

[78] Mora J.R., Rison R.A., Beudoun S.R. Chiari malformation type I with cervicothoracic syringomyelia masquerading as bibrachial amyotrophy: a case report // J Med Case Rep. 2015. Vol. 9. Р. 11. doi: 10.1186/1752-1947-9-11

[79] Gatselis NK, Skendros P, Ritis K, Dalekos GN. Severe liver involvement in two patients with long-term history of fever: remember familial Mediterranean fever. BMJ Case Rep. 2016;2016:bcr2016216941. doi: 10.1136/bcr-2016-216941

[80] Gatselis N.K., Skendros P., Ritis K., Dalekos G.N. Severe liver involvement in two patients with long-term history of fever: remember familial Mediterranean fever // BMJ Case Rep. 2016. Vol. 2016. Р. bcr2016216941. doi: 10.1136/bcr-2016-216941

[81] Liu YJ, Du P, Rao J. Procalcitonin as a diagnostic and prognostic marker for sepsis caused by intestinal infection: a case report. Eur Rev Med Pharmacol Sci. 2013;17(10):1311–1313.

[82] Liu Y.J., Du P., Rao J. Procalcitonin as a diagnostic and prognostic marker for sepsis caused by intestinal infection: a case report // Eur Rev Med Pharmacol Sci. 2013. Vol. 17, N 10. Р. 1311–1313.

[83] Hoffmann TC, Glasziou PP, Boutron I, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) Checklist and guide. BMJ. 2014;7(3):g1687. doi: 10.1055/s-0037-1600948

[84] Hoffmann T.C., Glasziou P.P., Boutron I., et al. Better reporting of interventions: template for intervention description and replication (TIDieR) Checklist and guide // BMJ. 2014. Vol. 7, N 3. Р. g1687. doi: 10.1055/s-0037-1600948

[85] Morino T, Ogata T, Horiuchi H, et al. Eight years of follow-up after laminectomy of calcium pyrophosphate crystal deposition in the cervical yellow ligament of patient with CoffineLowry syndrome: a case report. Medicine (Baltimore). 2016;95(31):e4468. doi: 10.1097/MD.0000000000004468

[86] Morino T., Ogata T., Horiuchi H., et al. Eight years of follow-up after laminectomy of calcium pyrophosphate crystal deposition in the cervical yellow ligament of patient with CoffineLowry syndrome: a case report // Medicine (Baltimore). 2016. Vol. 95, N 31. Р. e4468. doi: 10.1097/MD.0000000000004468

[87] Thomson N, Ulrickson M. Maintenance eculizumab dose adjustment in the treatment of atypical hemolytic uremic syndrome: a case report and review of the literature. Clin Case Rep. 2016;4(8):773–776. doi: 10.1002/ccr3.628

[88] Thomson N., Ulrickson M. Maintenance eculizumab dose adjustment in the treatment of atypical hemolytic uremic syndrome: a case report and review of the literature // Clin Case Rep. 2016. Vol. 4, N 8. Р. 773–776. doi: 10.1002/ccr3.628

[89] Tucker M, Kekulawala S, Kent M, et al. Polysubstance- induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case report. J Med Case Rep. 2016;10(1):242. doi: 10.1186/s13256-016-1031-3

[90] Tucker M., Kekulawala S., Kent M., et al. Polysubstance- induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case report // J Med Case Rep. 2016. Vol. 10, N 1. Р. 242. doi: 10.1186/s13256-016-1031-3

[91] Gupta S, Szerszen A, Nakhl F, et al. Severe refractory autoimmune hemolytic anemia with both warm and cold autoantibodies that responded completely to a single cycle of rituximab: a case report. J Med Case Rep. 2011;5:156. doi: 10.1186/1752-1947-5-156

[92] Gupta S., Szerszen A., Nakhl F., et al. Severe refractory autoimmune hemolytic anemia with both warm and cold autoantibodies that responded completely to a single cycle of rituximab: a case report // J Med Case Rep. 2011. Vol. 5. Р. 156. doi: 10.1186/1752-1947-5-156

[93] Oberg E, Rempe M, Bradley R. Self-directed mindfulness training and improvement in blood pressure, migraine frequency, and quality of life. Glob Adv Health Med. 2013;2(2):20–25. doi: 10.7453/gahmj.2013.006

[94] Oberg E., Rempe M., Bradley R. Self-directed mindfulness training and improvement in blood pressure, migraine frequency, and quality of life // Glob Adv Health Med. 2013. Vol. 2, N 2. Р. 20–25. doi: 10.7453/gahmj.2013.006

[95] Waqas M, Hadi YB, Sheikh S, Shamin SM. Acute cerebellitis successful managed with temporary cerebrospinal fluid diversion using a long tunnel external ventricular drain EVD: a long-term radiological follow-up of two cases. BMJ Case Rep. 2016; 2016:bcr2016215631. doi: 10.1136/bcr-2016-215631

[96] Waqas M., Hadi Y.B., Sheikh S., Shamin S.M. Acute cerebellitis successful managed with temporary cerebrospinal fluid diversion using a long tunnel external ventricular drain EVD: a long-term radiological follow-up of two cases // BMJ Case Rep. 2016. Vol. 2016. Р. bcr2016215631. doi: 10.1136/bcr-2016-215631

[97] Tamanna S, Ullah MI, Pope CR, et al. Quetiapine- induced sleep-related eating disorder like behavior: a case series. J Med Case Rep. 2012;6:380. doi: 10.1186/1752-1947-6-380

[98] Tamanna S., Ullah M.I., Pope C.R., et al. Quetiapine- induced sleep-related eating disorder like behavior: a case series // J Med Case Rep. 2012. Vol. 6. Р. 380. doi: 10.1186/1752-1947-6-380

[99] Aronson JK, Grahame-Smith DG. Altered distribution of digoxin in renal failureda case of digoxin toxicity? Br J Clin Pharmac. 1976;3(6):1045–1051. doi: 10.1111/j.1365-2125.1976.tb00356.x

[100] Aronson J.K., Grahame-Smith D.G. Altered distribution of digoxin in renal failureda case of digoxin toxicity? // Br J Clin Pharmac. 1976. Vol. 3, N 6. Р. 1045–1051. doi: 10.1111/j.1365-2125.1976.tb00356.x

[101] Hauben M, Aronson JK. Gold standards in pharmaco-vigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore. Drug Saf.2007;30:645–655. doi: 10.2165/00002018-200730080-00001

[102] Hauben M., Aronson J.K. Gold standards in pharmaco-vigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore // Drug Saf. 2007. Vol. 30. Р. 645–655. doi: 10.2165/00002018-200730080-00001

[103] Wicomb WN, Cooper DKC, Novitzky D, Barnard CN. Cardiac transplantation following storage of the donor heart by a portable hypothermic perfusion system. Ann Thorac Surg. 1984;37(3):243. doi: 10.1016/s0003-4975(10)60333-5

[104] Wicomb W.N., Cooper D.K., Novitzky D., Barnard C.N. Cardiac transplantation following storage of the donor heart by a portable hypothermic perfusion system // Ann Thorac Surg. 1984. Vol. 37, N 8. Р. 243. doi: 10.1016/s0003-4975(10)60333-5

[105] Morgan JA, John R, Weinberg AD, et al. Prolonged donor ischemic time does not adversely affect long-term survival in adult patients undergoing cardiac transplantation. J Thorac Cardiovasc Surg. 2003;126(5):1624–1633. doi: 10.1016/s0022-5223(03)01026-2

[106] Morgan J.A., John R., Weinberg A.D., et al. Prolonged donor ischemic time does not adversely affect long-term survival in adult patients undergoing cardiac transplantation // J Thorac Cardiovasc Surg. 2003. Vol. 126, N 5. Р. 1624–1633. doi: 10.1016/s0022-5223(03)01026-2

[107] Briganti EM, Bergin PJ, Rosenfeldt FL, et al. Successful long-term outcome with prolonged ischemic time cardiac allografts. J Heart Lung Transpl. 1995;14(5):840–845.

[108] Briganti E.M., Bergin P.J., Rosenfeldt F.L., et al. Successful long-term outcome with prolonged ischemic time cardiac allografts // J Heart Lung Transpl. 1995. Vol. 14, N 5. Р. 840–845.

[109] Del Rizzo DF, Menkis AH, Pflugfelder PW, et al. The role of donor age and ischemic time on survival following orthotopic heart transplantation. J Heart Lung Transpl. 1999;18(4):310–315. doi: 10.1016/s1053-2498(98)00059-x

[110] Del Rizzo D.F., Menkis A.H., Pflugfelder P.W., et al. The role of donor age and ischemic time on survival following orthotopic heart transplantation // J Heart Lung Transpl. 1999. Vol. 18, N 4. Р. 310–319. doi: 10.1016/s1053-2498(98)00059-x

[111] Canter C, Naftel D, Caldwell R, et al. Survival and risk factors for death after cardiac transplantation in infants: a multi-institutional study. Circ J. 1997;96(1):227. doi: 10.1161/01.cir.96.1.227

[112] Canter C., Naftel D., Caldwell R., et al. Survival and risk factors for death after cardiac transplantation in infants: a multi-institutional study // Circ J. 1997. Vol. 96, N 1. Р. 227. doi: 10.1161/01.cir.96.1.227

[113] Keogh MJ, Findlay JM, Leach S, Bowen J. Statin-associated weakness in myasthenia gravis: a case report. J Med Case Rep. 2010;4:61. doi: 10.1186/1752-1947-4-61

[114] Keogh M.J., Findlay J.M., Leach S., Bowen J. Statin-associated weakness in myasthenia gravis: a case report // J Med Case Rep. 2010. Vol. 4. Р. 61. doi: 10.1186/1752-1947-4-61

[115] Dickman H, Fletke K, Redfern RE. Prolonged unassisted survival in an infant with anencephaly. BMJ Case Rep. 2016;2016:bcr2016215986. doi: 10.1136/bcr-2016-215986

[116] Dickman H., Fletke K., Redfern R.E. Prolonged unassisted survival in an infant with anencephaly // BMJ Case Rep. 2016. Vol. 2016. Р. bcr2016215986. doi: 10.1136/bcr-2016-215986

[117] Lundberg GD. Sciatica: a Love story. Medscape; 2016.

[118] Lundberg G.D. Sciatica: a love story. Medscape; 2016.

[119] Kogan M, Castillo CC, Barber MS. Chronic Rhinosinusitis and Irritable Bowel syndrome: a case report. Integr Med (encinitas) J. 2016;15(3):44–48.

[120] Kogan M., Castillo C.C., Barber M.S. Chronic Rhinosinusitis and Irritable Bowel syndrome: a case report // Integr Med (encinitas) J. 2016. Vol. 15, N 3. Р. 44–48.

[121] BMJ Case Reports. Available from: http://casereports.bmj.com/site/about/guidelines.xhtml#patientconsent. Accessed: October 22,2016.

[122] BMJ Case Reports. Режим доступа: http://casereports.bmj.com/site/about/guidelines.xhtml#patientconsent. Дата обращения: 22.10.2016.

[123] Sackett DL, Rosenberg WM, Gray JA, et al. Evidence basedmedicine: what it is andwhat it isn’t. BMJ. 1996;312(7023):71. doi: 10.1136/bmj.312.7023.71

[124] Sackett D.L., Rosenberg W.M., Gray J.A., et al. Evidence basedmedicine: what it is andwhat it isn’t // BMJ. 1996. Vol. 312, N 7023. Р. 71. doi: 10.1136/bmj.312.7023.71

[125] Califf RM, Robb MA, Bindman AB, et al. Transforming evidence generation to support health and health care decisions. N Engl J Med. 2016;375(24):2395e440. doi: 10.1056/NEJMsb1610128

[126] Califf R.M., Robb M.A., Bindman A.B., et al. Transforming generation to support health and health care decisions // N Engl J Med. 2016. Vol. 375, N 24. Р. 2395–2440. doi: 10.1056/NEJMsb1610128

[127] Wacholder S, Chanock S, Garcia-Closas ME, et al. Assessing the probability that a positive report is false: an Approach for molecular Epidemiology studies. J Natl Cancer Inst. 2004;96(6):434–442. doi: 10.1093/jnci/djh075

[128] Wacholder S., Chanock S., Garcia-Closas M.E., et al. Assessing the probability that a positive report is false: an Approach for molecular Epidemiology studies // J Natl Cancer Inst. 2004. Vol. 96, N 6. Р. 434–442. doi: 10.1093/jnci/djh075

[129] Ioannidis JP. Why most clinical research is not useful. Plos Med. 2016;13(6):e1002049. doi: 10.1371/journal.pmed.1002049

[130] Ioannidis J.P. Why most clinical research is not useful // Plos Med. 2016. Vol. 13, N 6. Р. e1002049. doi: 10.1371/journal.pmed.1002049

[131] Buonfrate D, Requena-Mendez A, Angheben A, et al. Severe strongyloidiasis: a systematic review of case reports. BMC Infect Dis. 2013;13:78. doi: 10.1186/1471-2334-13-78

[132] Buonfrate D., Requena-Mendez A., Angheben A., et al. Severe strongyloidiasis: a systematic review of case reports // BMC Infect Dis. 2013. Vol. 13. Р. 78. doi: 10.1186/1471-2334-13-78

[133] IOM (Institute of Medicine). Clinical Practice Guidelines We Can Trust. Washington, DC: The National Academies Press; 2011.

[134] IOM (Institute of Medicine). Clinical Practice Guidelines We Can Trust. Washington, DC: The National Academies Press,2011.

[135] Barrows HS. A taxonomy of problem-based learning methods. Med Education. 1986;20(6):481–486. doi: 10.1111/j.1365-2923.1986.tb01386.x

[136] Barrows H.S. A taxonomy of problem-based learning methods // Med Education. 1986. Vol. 20, N 6. Р. 481–486. doi: 10.1111/j.1365-2923.1986.tb01386.x

[137] Irby DM. Three Exemplary model of case-based teaching. Acad Med. 1994;69(12):947–953. doi: 10.1097/00001888-199412000-00003

[138] Irby D.M. Three Exemplary model of case-based teaching // Acad Med. 1994. Vol. 69, N 12. Р. 947–953. doi: 10.1097/00001888-199412000-00003

[139] Kiene H, Hamre H, Kienle GS. In support of clinical case reports: a system of causality assessment. Glob Adv Health Med. 2013;2(2): 64–75. doi: 10.7453/gahmj.2012.061

[140] Kiene H., Hamre H., Kienle G.S. In support of clinical case reports: a system of causality assessment // Glob Adv Health Med. 2013. Vol. 2, N 2. Р. 64–75. doi: 10.7453/gahmj.2012.061

[141] Hay JE, Wiesner RH, Shorter RG, et al. Primary sclerosing cholangitis and celiac disease. A novel association. Ann Intern Med. 1988;109(9):713–717. doi: 10.7326/0003-4819-109-9-713

[142] Hay J.E., Wiesner R.H., Shorter R.G., et al. Primary sclerosing cholangitis and celiac disease. A novel association // Ann Intern Med. 1988. Vol. 109, N 9. Р. 713–717. doi: 10.7326/0003-4819-109-9-713

[143] Shamseer L, Sampson M, Bukutu C, et al. Cent group. CONSORT extension for reporting N-of-1 trials (CENT) 2015: explanation and elaboration. J Clin Epidemiol. 2016;76:18–46. doi: 10.1016/j.jclinepi.2015.05.018

[144] Shamseer L., Sampson M., Bukutu C., et al. Cent group. CONSORT extension for reporting N-of-1 trials (CENT) 2015: explanation and elaboration // J Clin Epidemiol. 2016. Vol. 76. Р. 18–46. doi: 10.1016/j.jclinepi.2015.05.018

[145] Badalov N, Baradarian R, Iswara K, et al. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007;5(6):548–561. doi: 10.1016/j.cgh.2006.11.023

[146] Badalov N., Baradarian R., Iswara K., et al. Drug-induced acute pancreatitis: an evidence-based review // Clin Gastroenterol Hepatol. 2007. Vol. 5, N 6. Р. 548–561. doi: 10.1016/j.cgh.2006.11.023

[147] Patsopoulos NA, Analatos AA, Ioannidis JP. Relative citation impact of various study design in the health sciences. JAMA. 2005;293:2362–2366. doi: 10.1001/jama.293.19.2362

[148] Patsopoulos N.A., Analatos A.A., Ioannidis J.P. Relative citation impact of various study design in the health sciences // JAMA. 2005. Vol. 293, N 19. Р. 2362–2366

RIGHTS & PERMISSIONS

Barber M.S., Aronson J.K., von Schoen-Angerer T., Riley D.S., Tugwell P., Kiene H., Helfand M., Altman D.G., Sox H., Werthmann P.G., Moher D., Rison R.A., Shamseer L., Koch C.A., Sun G., Hanaway P., Sudak N.L., Carpenter J.E., Gagnier J.J.